www.klinikum.uni-heidelberg.de/newsroom/12-...
1,2 Millionen Euro Förderung für die Herstellung von „Gen-Taxis“
Die Dietmar Hopp Stiftung unterstützt den Aufbau einer experimentellen Produktionseinheit für Gentherapien des Herzens an der Medizinischen Fakultät Heidelberg der Universität Heidelberg, in der Abtei...
klinikum.uni-heidelberg.de
Are you on the hunt for a novel AAV vector for cardiac gene therapy? We identified a promising candidate in human heart biopsies with great potential for cardiac-directed therapies. doi.org/10.1161/CIRC...
American Heart Association Journals
doi.org
First post here on a new publication from our lab 😄😄😄 I'm excited to share our latest work on cardiac gene therapy, where we show that AAV5 is effective in delivering S100A1 to the post-ischemic heart, achieving lasting improvement in cardiac performance.@dzhk.de www.ahajournals.org/doi/10.1161/...
Cardiac-Targeted AAV5-S100A1 Gene Therapy Protects Against Adverse Remodeling and Contractile Dysfunction in Postischemic Hearts | Circulation: Heart Failure
BACKGROUND: Guided by long-term safety data for AAV5 (adeno-associated virus 5) in humans, our translational study investigated whether AAV5 effectively delivers genes to healthy and achieves therapeu...
ahajournals.org
Breaking News: A baby with a rare disorder made medical history by receiving the first custom gene-editing treatment. The technique used has the potential to help people with thousands of other uncommon genetic diseases. nyti.ms/4j49xBy
